This list is an analysis based on recent market events. It's not an investment recommendation.
About
BioMaxima S.A. manufactures and distributes reagents for in vitro diagnostics in Poland. Its primary products include diagnostic reagents and analyzers for clinical chemistry; rapid tests and readers for detecting infectious diseases, cancer markers, cardiac markers, and drugs of abuse; urine analysis systems; hematology analyzers and reagents; ionselective analyzers and reagents; reagents and immunological analyzers of cardiac markers; glucometers for professional use; and analyzers for gasometric tests and critical blood parameters tests. The company also provides surfaces and air controls; antibiotics discs and MIC strips; and chromogenic, dehydrated, and prepared culture media; and additives and supplements for media. It supplies its products to approximately 2,000 laboratories in Poland, as well as exports in the international markets. BioMaxima S.A. was founded in 2002 and is based in Lublin, Poland.
The current price of BMX.WA is zł11.68 PLN — it has decreased by -0.85% in the past 24 hours. Watch Biomaxima SA stock price performance more closely on the chart.
What is Biomaxima SA stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Biomaxima SA stocks are traded under the ticker BMX.WA.
What is Biomaxima SA market cap?▼
Today Biomaxima SA has the market capitalization of 48.97M
What is Biomaxima SA revenue for the last year?▼
Biomaxima SA revenue for the last year amounts to 105.7M PLN.
What is Biomaxima SA net income for the last year?▼
BMX.WA net income for the last year is 1.07M PLN.
Does Biomaxima SA pay dividends?▼
Yes, BMX.WA dividends are paid annual. The last dividend per share was 0.5 PLN. As of today, Dividend Yield (FWD)% is 0%.
How many employees does Biomaxima SA have?▼
As of April 13, 2026, the company has 117 employees.
In which sector is Biomaxima SA located?▼
Biomaxima SA operates in the Health & Wellness sector.